|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.4 TWD | +1.05% |
|
+0.13% | +13.11% |
Sinphar Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 771.02 million compared to TWD 668.81 million a year ago. Net income was TWD 80.12 million compared to TWD 58.1 million a year ago.
Basic earnings per share from continuing operations was TWD 0.48 compared to TWD 0.35 a year ago. Diluted earnings per share from continuing operations was TWD 0.48 compared to TWD 0.35 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.11% | 196M | |
| +20.78% | 43.29B | |
| +27.64% | 22.38B | |
| +19.25% | 15.51B | |
| +18.68% | 14.52B | |
| +54.64% | 12.93B | |
| -0.05% | 6.79B | |
| -11.39% | 6.56B | |
| +18.33% | 5.87B | |
| -8.87% | 5.73B |
SINPHAR PHARMACEUTICAL CO.,LTD. 
